# Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome

> **NCT02614963** · PHASE4 · UNKNOWN · sponsor: **Shandong University** · enrollment: 300 (estimated)

## Conditions studied

- Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome

## Interventions

- **DRUG:** Clostridium Butyricum
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02614963
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2016-05-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02614963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02614963, "Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02614963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*